The effect of growth hormone on the metabolome of follicular fluid in patients with diminished ovarian reserve.
The effect of growth hormone on the metabolome of follicular fluid in patients with diminished ovarian reserve.
复制标题
DOI:
10.1186/s12958-023-01073-x
复制
发表时间:
2023-02-27
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Increasing evidence supports that the co-treatment with growth hormone (GH) enhances ovarian response and oocyte quality during controlled ovarian stimulation (COS) in patients with diminished ovarian reserve (DOR). The composition of follicular fluid (FF) plays an essential role in oocyte development and mirrors the communication occurring between the oocyte and follicular microenvironment. However, the effect of GH on the FF metabolome remains unclear. This prospective observational study recruited DOR patients undergoing in vitro fertilization (IVF) cycles with minimal stimulation protocol for COS. Each patient receiving GH co-treatment was matched to a patient without GH co-treatment by propensity score matching. The FF was collected after isolating oocytes and assayed by gas chromatograph-mass spectrometry (GC-MS) metabolomics. The Pearson correlation was performed to evaluate the relationship between the number of oocytes retrieved and the levels of differential metabolites. The KEGG database was used to map differential metabolites onto various metabolic pathways. One hundred thirty-four FF metabolites were identified by GC-MS metabolomics. Twenty-four metabolites, including glutathione, itaconic acid and S-adenosylmethionin (SAM) showed significant differences between the GH and control groups (p-value < 0.05 and q-value < 0.1). In addition, the number of oocytes retrieved was significantly higher in the GH group compared to the control group (3 vs 2, p = 0.04) and correlated with the levels of five differential metabolites. Among them, the levels of antioxidant metabolite itaconic acid were upregulated by GH administration, while SAM levels were downregulated. The co-treatment with GH during COS may improve oocyte development by altering FF metabolite profiles in DOR patients. However, given the downregulation of SAM, a regulator of genomic imprinting, the potential risk of imprinting disturbances should not be neglected. The online version contains supplementary material available at 10.1186/s12958-023-01073-x.
登录
查看更多内容
影响因子:
4.6
作者:
Hayashi Y;Kashio S;Murotomi K;Hino S;Kang W;Miyado K;Nakao M;Miura M;Kobayashi S;Namihira M
通讯作者:
Namihira M
影响因子:
6.1
作者:
de la Barca, J. M. Chao;Boueilh, T.;May-Panloup, P.
通讯作者:
May-Panloup, P.
影响因子:
6.7
作者:
Devine K;Mumford SL;Wu M;DeCherney AH;Hill MJ;Propst A
通讯作者:
Propst A
DOI:
10.1196/annals.1297.053
发表时间:
2004-01-01
期刊:
STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF AGING MAY BE FORESEEABLE
影响因子:
--
作者:
Brown-Borg, HM;Rakoczy, SG;Uthus, EO
通讯作者:
Uthus, EO
DOI:
10.1016/j.jogoh.2020.101982
发表时间:
2021-02-01
影响因子:
1.9
作者:
Dogan, Sare;Cicek, Ozge Senem Yucel;Sertel, Emre
通讯作者:
Sertel, Emre